Russell Investments Group’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-228
| Closed | -$381 | – | 3793 |
|
|
2024
Q4 | $381 | Buy |
228
+130
| +133% | +$217 | ﹤0.01% | 3635 |
|
|
2024
Q3 | $178 | Sell |
98
-2,233
| -96% | -$4.06K | ﹤0.01% | 3647 |
|
|
2024
Q2 | $14.1K | Buy |
+2,331
| New | +$14.1K | ﹤0.01% | 3004 |
|
|
2023
Q3 | – | Sell |
-269
| Closed | -$2.02K | – | 3517 |
|
|
2023
Q2 | $2.02K | Buy |
+269
| New | +$2.02K | ﹤0.01% | 3239 |
|
|
2023
Q1 | – | Sell |
-40,813
| Closed | -$460K | – | 3289 |
|
|
2022
Q4 | $460K | Hold |
40,813
| – | – | ﹤0.01% | 2320 |
|
|
2022
Q3 | $390K | Sell |
40,813
-38,774
| -49% | -$371K | ﹤0.01% | 2338 |
|
|
2022
Q2 | $642K | Buy |
79,587
+18,587
| +30% | +$150K | ﹤0.01% | 2162 |
|
|
2022
Q1 | $1.03M | Buy |
61,000
+19,570
| +47% | +$330K | ﹤0.01% | 1948 |
|
|
2021
Q4 | $889K | Buy |
41,430
+11,099
| +37% | +$238K | ﹤0.01% | 2206 |
|
|
2021
Q3 | $2.24M | Hold |
30,331
| – | – | ﹤0.01% | 1768 |
|
|
2021
Q2 | $1.66M | Buy |
+30,331
| New | +$1.66M | ﹤0.01% | 2031 |
|